Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.47 |
| ▸ | MLNR | O43193 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL650880 | 0.94 | LTA4H (0.47) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| Aluminum Chloride Anhydrous SCHEMBL28757318 | 0.93 | LTA4H (0.42) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL10639345 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL10420432 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL10334473 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL2941920 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL1720912 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL6036675 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL27947956 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 | |
| SCHEMBL5073229 | 0.92 | LTA4H (0.46) | LTA4HMLNRNR1I2ESR1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104224781-B | The pyridine compounds and their and its new application of one group of 2- amide groups -3- alkoxy substitution | 中国医学科学院医药生物技术研究所 | 2018-09-25 | — | — | CN | claimed |
| CN-101426805-A | Method for detaching protecting group on nucleic acid | NIPPON SHINYAKU CO LTD (JP) | 2009-05-06 | — | — | CN | claimed |
| JP-4237257-B2 | — | — | 2009-03-11 | — | — | JP | claimed |
| US-20060205938-A1 | Monohydrate solvates of loracarbef | RANBAXY LABORATORIES LIMITED (IN) | 2006-09-14 | — | — | US | claimed |
| EP-1565462-A1 | MONOHYDRATE SOLVATES OF LORACARBEF | RANBAXY LABORATORIES, LTD. (IN) | 2005-08-24 | — | — | EP | claimed |
| WO-2004046142-A1 | MONOHYDRATE SOLVATES OF LORACARBEF | RANBAXY LABORATORIES LIMITED (IN) | 2004-06-03 | — | — | WO | claimed |
| EP-1021388-B1 | PHOSPHORYLATION PROCESS AND CATALYST | BIONERIS AB (SE) | 2003-06-25 | — | — | EP | claimed |
| US-6479656-B1 | Phosphorylation process and catalyst | PERSTORP AB (SE) | 2002-11-12 | — | — | US | claimed |
| US-6468664-B1 | CAN BE APPLIED TO A PASSIVATION LAYER WITHOUT AN ADHESIVE AGENT OR AN ADHESIVE TAPE FOR PACKAGING LOC(LEAD-ON-CHIP) AND WHICH HAS AN EXCELLENT PHOTORESIST WETABILITY AND AN EXCELLENT ADHESION WITH BOTH A SILICON CHIP AND A LEAD FRAME. | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2002-10-22 | — | — | US | claimed |
| JP-2001501910-A | — | — | 2001-02-13 | — | — | JP | claimed |
| EP-1021388-A1 | PHOSPHORYLATION PROCESS AND CATALYST | PERSTORP AB (SE) | 2000-07-26 | — | — | EP | claimed |
| EP-0656008-B1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS INC (US) | 2000-03-15 | — | — | EP | claimed |
| EP-0920414-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.p.A. (IT) | 1999-06-09 | — | — | EP | claimed |
| US-5866681-A | OLIGOPEPTIDES | COR THERAPEUTICS, INC. (US) | 1999-02-02 | — | — | US | claimed |
| WO-1997049674-A1 | MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-12-31 | — | — | WO | claimed |
| JP-2675438-B2 | — | — | 1997-11-12 | — | — | JP | claimed |
| WO-1997034853-A1 | PHOSPHORYLATION PROCESS AND CATALYST | PERSTORP AB (SE) | 1997-09-25 | — | — | WO | claimed |
| EP-0656008-A1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1995-06-07 | — | — | EP | claimed |
| WO-1994003479-A1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1994-02-17 | — | — | WO | claimed |
| WO-1993013089-A1 | MACROCYCLIC POLYETHER CARBOXYLIC ACIDS | URBAN FRANK J (US) | 1993-07-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205938-A1 | Monohydrate solvates of loracarbef | SLC10A1, DCXR, KLK13 | LTA4H 219/4885MLNR 136/4885NR1I2 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.